SEGMENT AND GEOGRAPHIC AREA INFORMATION - Information regarding operations by segment (Details)		12 Months Ended
	Jul. 26, 2025 segment	Sep. 30, 2025 USD ($) segment	Sep. 30, 2024 USD ($)
SEGMENT INFORMATION
Number of reportable segments \| segment	3	2
Depreciation expense		$ 384,165	$ 432,595
Revenues:
Total revenues		2,136,935	2,113,490
Gross profit		838,907	974,840
Segment information
Selling, general and administrative		10,868,590	11,049,537
Research and development		6,016,912	3,593,750
Total operating expenses		16,885,502	14,643,287
(Loss) income from segment operations (a)		(16,046,595)	(13,668,447)
Product revenues
Revenues:
Total revenues		1,424,147	1,074,813
Service revenues
Revenues:
Total revenues		712,788	1,038,677
Therapeutic DNA Production
SEGMENT INFORMATION
Depreciation expense		344,008	164,275
DNA Tagging and Security Products
SEGMENT INFORMATION
Depreciation expense		40,157	266,677
Operating segment
Revenues:
Total revenues		2,136,935	3,431,419
Gross profit		838,907	1,016,879
Segment information
Selling, general and administrative		5,476,182	6,438,685
Research and development		5,576,506	3,408,663
Total operating expenses		11,052,688	9,847,350
(Loss) income from segment operations (a)		(10,213,781)	(8,830,469)
Operating segment \| Product revenues
Revenues:
Total revenues		1,424,147	1,074,813
Operating segment \| Service revenues
Revenues:
Total revenues		712,788	1,038,677
Operating segment \| Clinical laboratory service revenues
Revenues:
Total revenues			1,330,849
Operating segment \| Therapeutic DNA Production
Revenues:
Total revenues		988,118	895,354
Gross profit		336,666	678,167
Segment information
Selling, general and administrative		4,203,069	3,065,288
Research and development		5,436,239	2,402,151
Total operating expenses		9,639,308	5,467,439
(Loss) income from segment operations (a)		(9,302,642)	(4,789,272)
Operating segment \| Therapeutic DNA Production \| Product revenues
Revenues:
Total revenues		828,806	560,000
Operating segment \| Therapeutic DNA Production \| Service revenues
Revenues:
Total revenues		159,312	335,354
Operating segment \| MDx Testing Services
Revenues:
Total revenues			1,317,929
Gross profit			(49,831)
Segment information
Selling, general and administrative			1,127,462
Research and development			311,927
Total operating expenses			1,439,389
(Loss) income from segment operations (a)			(1,489,220)
Operating segment \| MDx Testing Services \| Clinical laboratory service revenues
Revenues:
Total revenues			1,330,849
Operating segment \| DNA Tagging and Security Products
Revenues:
Total revenues		1,148,817	1,218,136
Gross profit		502,241	388,543
Segment information
Selling, general and administrative		1,273,113	2,245,935
Research and development		140,267	694,585
Total operating expenses		1,413,380	2,940,520
(Loss) income from segment operations (a)		(911,139)	(2,551,977)
Operating segment \| DNA Tagging and Security Products \| Product revenues
Revenues:
Total revenues		595,341	514,813
Operating segment \| DNA Tagging and Security Products \| Service revenues
Revenues:
Total revenues		$ 553,476	703,323
Less intersegment revenues
Revenues:
Total revenues			(12,920)
Less intersegment revenues \| MDx Testing Services
Revenues:
Total revenues			$ (12,920)

BNB PLUS CORP. 10-K